M. Warren

发表

AIDS vaccine research and advocacy: an update.

E. Bass, C. Feuer, M. Warren, 2009, BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation.

Expanding Safer Sex Options: Introducing the Female Condom into National Programmes

M. Warren, A. Philpott, 2003, Reproductive health matters.

Meeting reportPlanning for pre-exposure prophylaxis to prevent HIV transmission : challenges and opportunities

M. Dybul, J. Mellors, P. Piot, 2018 .

Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on ‘Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines’, 31 January–2 February 2006, IAVI, New York, USA

H. Rees, S. Self, P. Kaleebu, 2007, AIDS.

Gender, age, and ethnicity in HIV vaccine-related research and clinical trials: Report from a WHO–UNAIDS consultation, 26–28 August 2004. Lausanne, Switzerland

J. Fuchs, C. Obermeyer, J. Safrit, 2005, AIDS.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Multi-stakeholder consensus on a target product profile for an HIV cure

T. Ndung’u, M. Dybul, S. Lewin, 2020, The lancet. HIV.

Voluntary Medical Male Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age and Geography

C. Hankins, E. Njeuhmeli, M. Warren, 2016, PloS one.

Ethical considerations in determining standard of prevention packages for HIV prevention trials: examining PrEP.

S. McCormack, G. Ramjee, B. Haire, 2013, Developing world bioethics.

The case for an HIV cure and how to get there

Maureen M Goodenow, T. Ndung’u, M. Dybul, 2020, The lancet. HIV.

HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights

T. Hope, L. Morris, C. A. Derdeyn, 2017, AIDS research and human retroviruses.

Antiretroviral pre-exposure prophylaxis implementation in the United States: a work in progress

R. Grant, Stephanie E Cohen, K. Mayer, 2015, Journal of the International AIDS Society.

Safety, functionality and acceptability of a prototype polyurethane condom

M. Warren, G. Farr, R. Amatya, 1997, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

Correction: Voluntary Medical Male Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age and Geography

C. Hankins, E. Njeuhmeli, M. Warren, 2016, PloS one.

Call to action: how can the US Ending the HIV Epidemic initiative succeed?

A. Adimora, P. Sullivan, R. Walensky, 2021, The Lancet.

How Can We Get Close to Zero? The Potential Contribution of Biomedical Prevention and the Investment Framework towards an Effective Response to HIV

T. Hallett, J. Montaner, P. Ghys, 2014, PloS one.

Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-Saharan Africa

M. Dunbar, J. Haberer, P. Patel, 2018, Sexual health.

HIV Prevention 2020: a framework for delivery and a call for action.

G. Garnett, G. Dallabetta, M. Laga, 2016, The lancet. HIV.

Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access

R. Macklin, C. Hankins, M. Warren, 2015, Journal of the International AIDS Society.

HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021

Philip Smith, P. Sullivan, S. McCormack, 2021, AIDS research and human retroviruses.

Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.

Michael I. Jordan, S. Delany-Moretlwe, R. Paredes, 2023, The lancet. HIV.

Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities

M. Dybul, J. Mellors, P. Piot, 2010, Journal of the International AIDS Society.

P15-21. Investigating the utility and relevance of the good participatory practice guidelines for biomedical HIV prevention trials

E. Bass, C. Feuer, M. Warren, 2009, Retrovirology.

From efficacy to impact: an advocate's agenda for HIV pre-exposure prophylaxis implementation.

E. Bass, M. Warren, 2013, American journal of preventive medicine.

Providing a conceptual framework for HIV prevention cascades and assessing feasibility of empirical measurement with data from east Zimbabwe: a case study

T. Hallett, G. Garnett, S. Gregson, 2016, The lancet. HIV.

Perspectives on HIV Prevention: Priorities for a New Era

E. Bass, M. Warren, 2013, Journal of acquired immune deficiency syndromes.

reportPlanning for pre-exposure prophylaxis to prevent HIV transmission : challenges and opportunities

M. Dybul, J. Mellors, P. Piot, 2010 .

Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low- and Middle-Income Countries

Margaret G. McGlynn, J. Stover, M. Warren, 2016, PloS one.

Turning the Tide Against HIV

S. McCormack, R. Shattock, C. Hankins, 2011, Science.

The complex challenges of HIV vaccine development require renewed and expanded global commitment

Maureen M Goodenow, Jerome H. Kim, T. Ndung’u, 2019, The Lancet.

Designing research in vulnerable populations: lessons from HIV prevention trials that stopped early

Ross Upshur, Sonal Singh, E. Mills, 2005, BMJ : British Medical Journal.

Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age

C. Hankins, E. Njeuhmeli, M. Warren, 2018 .

HIV Research for Prevention 2018: From Research to Impact Conference Summary and Highlights

S. Buchbinder, C. Herrera, N. Mgodi, 2019, AIDS research and human retroviruses.

The science of Durban, AIDS 2016

H. Rees, W. El-Sadr, C. Beyrer, 2017, Journal of the International AIDS Society.